KPP Advisory Services’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
KPP Advisory Services's HQL Position: Q2 2026 in Review
KPP Advisory Services increased its abrdn Life Sciences Investors (HQL) stake by 2.7% in Q2 2026, buying an estimated $11.7K and bringing the position to 25,251 shares worth $505K. The position accounts for 0.06% of the portfolio, ranked #227.
KPP Advisory Services first reported a position in HQL in Q3 2023 and has held it in 11 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- KPP Advisory Services held 25,251 shares of abrdn Life Sciences Investors worth $505K as of Q2 2026.
- KPP Advisory Services bought 660 abrdn Life Sciences Investors shares in Q2 2026, an estimated $11.7K.
- abrdn Life Sciences Investors made up 0.06% of KPP Advisory Services's portfolio in Q2 2026, its #227 holding.
- KPP Advisory Services first reported a position in abrdn Life Sciences Investors in Q3 2023 and has held it in 11 quarters since.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.